Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (401-410 of 715) with videos related to

Pageof 72
Sort By:
European Journal of Biochemistry|March 15, 1997
Enzymatic properties of phage-displayed fragments of human plasminogenI Lasters, N Van Herzeele, H R Lijnen, et al.
Circulation|May 11, 1999
Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in miceN Nagai, M De Mol, H R Lijnen, et al.
British Journal of Pharmacology|October 13, 2000
The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in miceH Matsuno, O Kozawa, S Ueshima, et al.
European Journal of Biochemistry|February 13, 2001
Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3)B Arza, M De Maeyer, J Félez, et al.
Thrombosis and Haemostasis|July 15, 2000
CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in miceH R Lijnen, F Lupu, D Collen, et al.
Journal of the American College of Cardiology|May 1, 1992
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dogH R Lu, Z Wu, P Pauwels, et al.
Circulation|October 14, 1998
Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery diseaseP Holvoet, J Vanhaecke, S Janssens, et al.
Blood|May 1, 1990
A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasmaP J Declerck, H R Lijnen, M Verstreken, et al.
European Journal of Biochemistry|October 1, 1979
Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasminS A Cederholm-Williams, F De Cock, H R Lijnen, et al.
Biochemistry|June 4, 1998
Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)F Ugwu, B Van Hoef, A Bini, et al.
Pageof 72

Showing results (401-410 of 715) with videos related to

Sort By:
Pageof 72
European Journal of Biochemistry|March 15, 1997
Enzymatic properties of phage-displayed fragments of human plasminogenI Lasters, N Van Herzeele, H R Lijnen, et al.
Circulation|May 11, 1999
Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in miceN Nagai, M De Mol, H R Lijnen, et al.
British Journal of Pharmacology|October 13, 2000
The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in miceH Matsuno, O Kozawa, S Ueshima, et al.
European Journal of Biochemistry|February 13, 2001
Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3)B Arza, M De Maeyer, J Félez, et al.
Thrombosis and Haemostasis|July 15, 2000
CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in miceH R Lijnen, F Lupu, D Collen, et al.
Journal of the American College of Cardiology|May 1, 1992
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dogH R Lu, Z Wu, P Pauwels, et al.
Circulation|October 14, 1998
Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery diseaseP Holvoet, J Vanhaecke, S Janssens, et al.
Blood|May 1, 1990
A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasmaP J Declerck, H R Lijnen, M Verstreken, et al.
European Journal of Biochemistry|October 1, 1979
Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasminS A Cederholm-Williams, F De Cock, H R Lijnen, et al.
Biochemistry|June 4, 1998
Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)F Ugwu, B Van Hoef, A Bini, et al.
Pageof 72